SCHEMBL10747112

SCHEMBL10747112

S=c1c2ccccc2[se]n1-c1ccc2ccccc2n1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ HRH3 Q9Y5N1 6/20 0.40
▸ ALDH1A1 P00352 5/20 0.40
▸ KDM4E B2RXH2 4/20 0.40
▸ CYP1A2 P05177 3/20 0.40
▸ TDP1 Q9NUW8 3/20 0.40
▸ HTR3E A5X5Y0 2/20 0.40
▸ HTR3B O95264 2/20 0.40
▸ HTR3A P46098 2/20 0.40
▸ HTR3D Q70Z44 2/20 0.40
▸ HTR3C Q8WXA8 2/20 0.40
▸ CYP3A4 P08684 2/20 0.40
▸ HTT P42858 2/20 0.40
▸ PMP22 Q01453 2/20 0.40
▸ HSD17B10 Q99714 2/20 0.40
▸ THPO P40225 2/20 0.40
▸ USP2 O75604 1/20 0.40
▸ ADRB1 P08588 1/20 0.40
▸ HTR1A P08908 1/20 0.40
▸ HTR2C P28335 1/20 0.40
▸ MAPK1 P28482 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5916571 0.81 METAP2 (0.54) ALDH1A1KDM4ETDP1CYP3A4HTT
SCHEMBL10502063 0.75 METAP2 (0.39) ALDH1A1KDM4ETDP1HTR3EHTR3B
SCHEMBL10502474 0.74 ALDH1A1 (0.38) ALDH1A1KDM4ETDP1CYP3A4HTT
SCHEMBL10501746 0.73 METAP2 (0.43) ALDH1A1KDM4ETDP1CYP3A4HTT
SCHEMBL10501733 0.73 METAP2 (0.36) ALDH1A1KDM4ETDP1CYP3A4HTT
SCHEMBL10748283 0.72 METAP2 (0.36) ALDH1A1KDM4ETDP1CYP3A4HTT
SCHEMBL10748013 0.72 METAP2 (0.36) ALDH1A1KDM4ETDP1CYP3A4HTT
SCHEMBL10746688 0.71 KDM4E (0.35) ALDH1A1KDM4ETDP1CYP3A4HTT
SCHEMBL10501589 0.71 METAP2 (0.61) ALDH1A1KDM4ETDP1CYP3A4HTT
SCHEMBL10747356 0.70 AURKA (0.44) ALDH1A1KDM4EHTR3AHSD17B10NPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-4711961-A Benzisoselenazolethiones and process for the treatment of various diseases in humans A. NATTERMANN & CIE GMBH (DE) 1987-12-08 — — US disclosed
EP-0154851-A1 Benzisoselenazolethiones,process for their preparation and pharmaceutical products containing these compounds A. Nattermann & Cie. GmbH (DE) 1985-09-18 — — EP disclosed
Send feedback